C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2001
11/15/2001	WO2001085942A2 Cytoskeleton-associated proteins
11/15/2001	WO2001085938A1 Modified es cells and es cell-specific gene
11/15/2001	WO2001085937A2 Regulator of g protein signalling (rgs8)
11/15/2001	WO2001085936A1 F-box containing protein
11/15/2001	WO2001085935A2 Endothelial differentiation gene 6-like g protein coupled receptor
11/15/2001	WO2001085934A1 New ras guanine-nucleotide-exchange factor 1 (nrg1)
11/15/2001	WO2001085926A2 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
11/15/2001	WO2001085912A2 Presenilin enhancers
11/15/2001	WO2001085911A2 Chromosome 17p-linked prostate cancer susceptibility gene and a paralog and orthologous genes
11/15/2001	WO2001085798A2 Human monoclonal antibodies to dendritic cells
11/15/2001	WO2001085797A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
11/15/2001	WO2001085792A2 Mu-1, member of the cytokine receptor family
11/15/2001	WO2001085790A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
11/15/2001	WO2001085789A2 Extracellular domain of ryk protein for regulating angiogenesis
11/15/2001	WO2001085785A2 Ph domain-interacting protein
11/15/2001	WO2001085779A2 Protein complexes and assays for screening anti-cancer agents
11/15/2001	WO2001085770A2 Sentinel virus ii
11/15/2001	WO2001085762A2 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001	WO2001085204A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	WO2001085203A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	WO2001085192A1 Transgenically produced decorin
11/15/2001	WO2001036001A3 Interferon gamma conjugates
11/15/2001	WO2001032882A3 Nucleic acids and proteins from group b streptococcus
11/15/2001	WO2001032878A3 A novel polypeptide hormone phosphatonin
11/15/2001	WO2001016292A8 37 staphylococcus aureus genes and polypeptides
11/15/2001	WO2001004344A3 Induction of a th1-like response in vitro
11/15/2001	WO2001002594A3 DNA CONSTRUCTS BASED ON THE eIF4A GENE PROMOTER
11/15/2001	WO2000078344A8 Prion protein peptides and uses thereof
11/15/2001	WO2000063379A3 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
11/15/2001	WO2000058365A9 Specific binding proteins for treating canine allergy
11/15/2001	WO2000053232A9 Matriptase, a serine protease and its applications
11/15/2001	WO2000047715A3 Dwf4 polynucleotides, polypeptides and uses thereof
11/15/2001	WO2000026370A9 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/15/2001	US20010042255 Nucleic acids
11/15/2001	US20010041361 Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
11/15/2001	US20010041356 Novel subunits of NADH dehydrogenase
11/15/2001	US20010041354 Genetic engineering
11/15/2001	US20010041340 Genetic engineering
11/15/2001	US20010041334 Genetic engineering
11/15/2001	US20010041173 Helper-dependent cloning vectors where most viral genes have been removed and have increased safety and capacity for larger insertions
11/15/2001	CA2415688A1 Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals
11/15/2001	CA2409515A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
11/15/2001	CA2409510A1 Method for detecting growth hormone variations in humans, the variations and their uses
11/15/2001	CA2408921A1 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof
11/15/2001	CA2408732A1 Modified es cells and es cell-specific gene
11/15/2001	CA2408665A1 Novel regulator of g protein signalling
11/15/2001	CA2408664A1 F-box containing protein
11/15/2001	CA2408652A1 A method for designing and screening random libraries of compounds
11/15/2001	CA2408632A1 Ph domain-interacting protein
11/15/2001	CA2408594A1 Human monoclonal antibodies to dendritic cells
11/15/2001	CA2408576A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001	CA2408571A1 Mammalian receptor proteins; related reagents and methods
11/15/2001	CA2408549A1 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	CA2408547A1 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	CA2408349A1 Method of regulating angiogenesis unsing ryk protein
11/15/2001	CA2408297A1 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001	CA2408213A1 Protein complexes and assays for screening anti-cancer agents
11/15/2001	CA2408166A1 Presenilin enhancers
11/15/2001	CA2408124A1 Transgenically produced decorin
11/15/2001	CA2408051A1 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
11/15/2001	CA2408038A1 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor
11/15/2001	CA2408002A1 Enzymatic assays for screening anti-cancer agents
11/15/2001	CA2407937A1 New ras guanine-nucleotide-exchange factor 1 (nrg1)
11/15/2001	CA2407850A1 Cytoskeleton-associated proteins
11/15/2001	CA2406644A1 Sentinel virus ii
11/14/2001	EP1154019A2 G-protein coupled receptor (HFGAN72X)
11/14/2001	EP1153932A1 Novel g protein-coupled receptor protein and dna thereof
11/14/2001	EP1153121A2 Secreted proteins and polynucleotides encoding them
11/14/2001	EP1153035A2 Human lipid-associated proteins
11/14/2001	EP1152769A1 Yeast cell wall peptides and antibodies thereto
11/14/2001	EP1066380B1 Soluble t cell receptor
11/14/2001	EP0763117B1 Synthetic leader peptide sequences
11/14/2001	EP0715653B1 Humanised antibodies
11/14/2001	EP0688360B1 Bone stimulating factor
11/14/2001	EP0546110B1 New insulin-like growth factor binding protein igfbp-5
11/14/2001	EP0546074B1 Genetic material encoding igfbp-5
11/14/2001	EP0484369B1 Modified bioluminescent proteins and their use
11/14/2001	CN1322253A Overexpression of desired proteins in eukaryotic cells mediated by cyclin D1 overexpression
11/14/2001	CN1322251A Mutant human hepatitis B viral strain and uses thepeof
11/14/2001	CN1322246A Restin and methods of use thereof
11/14/2001	CN1322244A Tumor necrosis factor-gamma
11/14/2001	CN1322214A Induction of antiobiotic proteins and peptides by LAIT/sCD14-protein
11/14/2001	CN1321745A Macrophage inflammatory protein -3, -4 and -1 gamma
11/14/2001	CN1321469A Pinctada martensii visceral organs glycoprotein and glycosaminoglycan with tumor-resisting activity and their extraction process
11/13/2001	USRE37447 Modified Kluyveromyces yeasts, their preparation and use
11/13/2001	US6316611 Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefor
11/13/2001	US6316609 Nucleotide sequence of Escherichia coli pathogenicity islands
11/13/2001	US6316601 Antibodies specific for β6 integrins
11/13/2001	US6316600 Generating monoclonal antibodies; immunize poultry, isolate and immortalize lymphocytes, transform with vector, culture cells, recover antibodies
11/13/2001	US6316597 Protein for use in treatment of bone or cartilage defects
11/13/2001	US6316412 Polypeptides for promoting cell attachment
11/13/2001	US6316408 Methods of use for osetoprotegerin binding protein receptors
11/13/2001	US6316403 Deactivation of factor ix for coagulation inhibition and antiischemic agents
11/13/2001	US6316253 Plasmid for use as a tool in genetic engineering and gene transfer
11/13/2001	US6316250 Molecular clones producing recombinant DNA antigens of the hantavirus-associated respiratory distress (HARDS)
11/13/2001	US6316244 E. coli, Salmonella or Hafnia autoinducers
11/13/2001	US6316239 HKABY60 kinase family polypeptides
11/13/2001	US6316237 Respiratory nitrate reductase alpha subunit
11/13/2001	US6316227 Dna sequence encoding a composite heavy chain of a recombinant antibody molecule that specifically binds human interleukin-5 antigen
11/13/2001	US6316226 For use in treatment of hemophilia a

1 ... 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 ... 1125